Special Populations Considerations — MCQs

10 questions

A 72 year old lady is severely depressed. For the past 2 days she has suicidal thoughts with an actual intent to die. Which of the following is best suitable to alleviate the symptoms?

A 45-year-old patient with a history of depression was initially being treated with sertraline, but his symptoms were not adequately controlled. His medication regimen was changed to include an MAO inhibitor and amitriptyline. Shortly after the change in medication, the patient developed agitation, seizures, hyperreflexia, and tremor. Which of the following is the most appropriate treatment for this patient?

Which of the following medications is primarily an antipsychotic rather than a mood stabilizer and is NOT typically used for long-term prophylaxis in bipolar disorder? Chlorpromazine, Lithium, Carbamazepine, Sodium Valproate.

Which of the following is the most appropriate treatment for an overactive bladder in a patient with dementia?

A 29 year old lady came to psychiatry OPD with symptoms of hypomania. She has a past history of manic episode. Now, she is planning to conceive. Which drug should be avoided for being highly teratogenic to the fetus?

The preferred drug for treating ADHD in a 7-year-old boy, whose father has a history of substance abuse:

Which antihypertensive is considered the first-line treatment with the most extensive safety data for chronic hypertension in pregnancy?

Q9Easy

Clozapine is used in:

Q10Medium

Which antipsychotic has anti-suicidal properties?

Special Populations Considerations Indian Medical PG Practice Questions and MCQs

Question 1: A 72 year old lady is severely depressed. For the past 2 days she has suicidal thoughts with an actual intent to die. Which of the following is best suitable to alleviate the symptoms?

A. ECT (Correct Answer)
B. Selegiline
C. Haloperidol + Chlorpromazine
D. Amitriptyline

Explanation: ***ECT (Electroconvulsive Therapy)*** - **ECT** is the most effective and rapid treatment for severe depression, especially when associated with active **suicidal ideation** and intent. - Its quick onset of action (often within days) makes it vital in situations requiring urgent symptom alleviation to ensure patient safety. - **First-line treatment** for geriatric depression with suicidal risk and when rapid response is needed. *Selegiline* - **Selegiline** is a monoamine oxidase inhibitor (MAOI) used for depression and Parkinson's disease, but its antidepressant effects are not immediate. - It would not sufficiently address the patient's acute suicidal intent due to its slower therapeutic onset (several weeks). *Haloperidol + Chlorpromazine* - This combination consists of **antipsychotics**, primarily used for conditions with psychotic features or severe agitation but not as a primary treatment for severe depression with suicidal ideation. - While they might provide some sedation, they do not treat the underlying depressive disorder effectively and rapidly enough to resolve acute suicidal intent. *Amitriptyline* - **Amitriptyline** is a tricyclic antidepressant (TCA) that can be effective for depression but has a delayed onset of action (2-4 weeks). - **Highly contraindicated in suicidal patients** due to its extreme lethality in overdose (cardiotoxic effects). - Its slow therapeutic effect would not be appropriate for an urgent situation involving active suicidal thoughts with intent.

Question 2: A 45-year-old patient with a history of depression was initially being treated with sertraline, but his symptoms were not adequately controlled. His medication regimen was changed to include an MAO inhibitor and amitriptyline. Shortly after the change in medication, the patient developed agitation, seizures, hyperreflexia, and tremor. Which of the following is the most appropriate treatment for this patient?

A. Cyproheptadine (Correct Answer)
B. Lorazepam
C. L-carnitine
D. Leucovorin
E. Dantrolene

Explanation: ***Cyproheptadine*** - This patient exhibits symptoms of **serotonin syndrome** (agitation, seizures, hyperreflexia, tremor) due to the combination of an **MAO inhibitor** and **amitriptyline**. - **Cyproheptadine** is a **serotonin antagonist** and is the most appropriate treatment for reversing the effects of serotonin syndrome. - Treatment also includes discontinuing offending agents and supportive care. *Lorazepam* - **Lorazepam** is a **benzodiazepine** that can help manage agitation and seizures, but it does not address the underlying serotonin overstimulation. - It would be used as an adjunct for symptom control, not as the primary treatment for serotonin syndrome. *Dantrolene* - **Dantrolene** is a **muscle relaxant** used for **neuroleptic malignant syndrome (NMS)** and **malignant hyperthermia**. - While NMS and serotonin syndrome can have overlapping features (hyperthermia, rigidity), dantrolene is not indicated for serotonin syndrome. - Cyproheptadine is the specific serotonin antagonist needed for this condition. *L-carnitine* - **L-carnitine** is a supplement often used for conditions like **carnitine deficiency** or certain **metabolic disorders**. - It has no role in the treatment of serotonin syndrome. *Leucovorin* - **Leucovorin** (folinic acid) is used to **rescue bone marrow** from the toxic effects of **methotrexate** or to enhance the effects of **fluorouracil**. - It is not indicated for the treatment of serotonin syndrome.

Question 3: Which of the following medications is primarily an antipsychotic rather than a mood stabilizer and is NOT typically used for long-term prophylaxis in bipolar disorder? Chlorpromazine, Lithium, Carbamazepine, Sodium Valproate.

A. Chlorpromazine (Correct Answer)
B. Sodium Valproate
C. Carbamazepine
D. Lithium

Explanation: ***Chlorpromazine*** - **Chlorpromazine** is a **first-generation antipsychotic** primarily used to treat **psychotic symptoms** like hallucinations and delusions. - While it can be used for acute agitation in bipolar disorder, it's generally **not considered a first-line agent** for **long-term mood stabilization** or prophylaxis due to its side effect profile and limited efficacy in preventing mood episodes compared to true mood stabilizers. *Carbamazepine* - **Carbamazepine** is an **anticonvulsant medication** well-established as a **mood stabilizer** for the long-term prophylaxis and treatment of bipolar disorder. - It is particularly effective for **rapid cycling** and **mixed features**, distinguishing it from an antipsychotic. *Sodium Valproate* - **Sodium valproate** (Valproic acid) is a widely used **mood stabilizer** for both acute mania and long-term prophylaxis in bipolar disorder. - It is effective in treating or preventing both manic and depressive episodes, and is **not primarily an antipsychotic**. *Lithium* - **Lithium** is considered the **gold standard mood stabilizer** for the long-term prophylaxis of bipolar disorder, significantly reducing the risk of both manic and depressive episodes. - It is primarily a **mood stabilizer** and does not possess significant antipsychotic effects on its own.

Question 4: Which of the following is the most appropriate treatment for an overactive bladder in a patient with dementia?

A. Tolterodine (Correct Answer)
B. Mirabegron
C. Behavioral therapy/bladder training
D. Oxybutynin
E. Trospium

Explanation: ***Tolterodine*** - **Tolterodine** is a **muscarinic antagonist** that blocks acetylcholine receptors in the bladder, reducing detrusor muscle contractions and overactive bladder symptoms. - Unlike some other anticholinergics like oxybutynin, it has a **lower propensity to cross the blood-brain barrier** and thus a reduced risk of exacerbating cognitive impairment in patients with dementia. *Mirabegron* - **Mirabegron** is a **beta-3 adrenergic agonist** that relaxes the detrusor muscle, increasing bladder capacity. - While it has a different mechanism of action and is less likely to cause anticholinergic cognitive side effects than older anticholinergics, it can still cause **hypertension** and **tachycardia**, which may be problematic in elderly patients with comorbidities. *Behavioral therapy/bladder training* - **Behavioral therapy** and **bladder training** are important first-line treatments for overactive bladder. - However, for patients with **dementia**, cognitive impairment often makes adherence to and understanding of these complex therapies challenging or impossible without significant caregiver support. *Oxybutynin* - **Oxybutynin** is an **anticholinergic drug** that is effective for overactive bladder. - However, it has a **high affinity for muscarinic receptors** in the brain and readily crosses the blood-brain barrier, significantly increasing the risk of **cognitive impairment, confusion, and delirium** in elderly patients, especially those with pre-existing dementia. *Trospium* - **Trospium** is a **quaternary amine anticholinergic** that is hydrophilic and has minimal blood-brain barrier penetration. - While theoretically safer than oxybutynin in terms of CNS effects, it has **lower bladder selectivity** compared to tolterodine and may cause more peripheral anticholinergic side effects (dry mouth, constipation).

Question 5: A 29 year old lady came to psychiatry OPD with symptoms of hypomania. She has a past history of manic episode. Now, she is planning to conceive. Which drug should be avoided for being highly teratogenic to the fetus?

A. Oxcarbazepine
B. Lithium
C. Olanzapine
D. Valproate (Correct Answer)

Explanation: ***Valproate*** - **Valproate** is highly **teratogenic** and is associated with multiple birth defects, including **neural tube defects** (e.g., spina bifida), cardiac anomalies, and craniofacial defects. - Due to its significant risks, it is generally **contraindicated** in women of childbearing potential, especially during pregnancy, unless no other suitable alternatives exist. *Oxcarbazepine* - While it has some teratogenic risk (e.g., cleft palate), the risk is generally considered **lower than valproate**. - It is often favored over valproate in pregnant women requiring mood stabilizers, but still requires careful risk-benefit assessment. *Lithium* - **Lithium** is associated with an increased risk of **Ebstein's anomaly**, a specific cardiac defect, if used during the first trimester. - However, the overall risk of major malformations is still **lower than valproate**, and it can be used with careful monitoring if other options are not viable. *Olanzapine* - **Olanzapine** is an **atypical antipsychotic** that can be used as a mood stabilizer and is considered to have a **relatively lower teratogenic risk** compared to anticonvulsants like valproate. - While it's not entirely risk-free (associated with gestational diabetes and fetal growth issues), it's often a safer option in pregnancy for bipolar disorder than valproate.

Question 6: The preferred drug for treating ADHD in a 7-year-old boy, whose father has a history of substance abuse:

A. Clonidine
B. Atomoxetine (Correct Answer)
C. Dexamphetamine
D. Methylphenidate

Explanation: ***Atomoxetine*** - As a **non-stimulant**, atomoxetine is preferred in patients where stimulant use is contraindicated or when there's a concern for **substance abuse potential**, such as a parental history. - It specifically inhibits the **norepinephrine transporter**, leading to increased norepinephrine levels in the prefrontal cortex, improving ADHD symptoms. *Clonidine* - While clonidine is sometimes used for ADHD, particularly for **hyperactivity** or **tics**, it is not generally considered first-line and can cause **sedation**. - Its mechanism primarily involves stimulating central alpha-2 adrenergic receptors, which can help with impulse control but is distinct from the primary action of atomoxetine. *Dexamphetamine* - This is a **stimulant medication** and is highly effective for ADHD, but it carries a higher potential for **abuse and diversion**, making it less suitable given a family history of substance abuse. - Its mechanism involves increasing dopamine and norepinephrine levels in the brain, which can be reinforcing and contribute to its abuse potential. *Methylphenidate* - Similar to dexamphetamine, methylphenidate is a **stimulant** and a first-line treatment for ADHD, but its potential for **abuse** makes it a less desirable choice in this specific clinical context. - It acts as a norepinephrine-dopamine reuptake inhibitor, increasing the availability of these neurotransmitters, but like other stimulants, its controlled substance status is a concern.

Question 7: Which antihypertensive is considered the first-line treatment with the most extensive safety data for chronic hypertension in pregnancy?

A. Methyldopa (Correct Answer)
B. Labetalol
C. Hydralazine
D. ACE inhibitors

Explanation: ***Methyldopa*** - **Methyldopa** has been used for decades to treat **chronic hypertension in pregnancy** and has the most extensive data demonstrating its safety for both the mother and the fetus. - It is a centrally acting **alpha-2 adrenergic agonist** that reduces sympathetic outflow, leading to vasodilation and decreased blood pressure. *Labetalol* - **Labetalol** is an **alpha and beta-blocker** also considered a first-line agent, but its long-term safety data in pregnancy is not as extensive as methyldopa. - It is often used as an alternative or in cases where methyldopa is not sufficiently effective, especially for more acute or severe hypertension. *Hydralazine* - **Hydralazine** is a **direct vasodilator** often used for **hypertensive emergencies** in pregnancy, especially for managing severe hypertension or preeclampsia. - It is not typically recommended as a first-line agent for **chronic hypertension** due to a higher incidence of side effects like reflex tachycardia and fluid retention when used long-term. *ACE inhibitors* - **ACE inhibitors** (and ARBs) are **contraindicated in pregnancy** due to their association with severe fetal adverse effects, including **renal malformations**, **oligohydramnios**, and **fetal death**. - Their use should be avoided throughout pregnancy, and women on these medications should switch to safer alternatives upon conception or when planning pregnancy.

Question 8: Match the following drugs in Column A with their contraindications in Column B. | Column A | Column B | | :-- | :-- | | 1. Morphine | 1. QT prolongation | | 2. Amiodarone | 2. Thromboembolism | | 3. Vigabatrin | 3. Pregnancy | | 4. Estrogen preparations | 4. Head injury |

A. A-1, B-3, C-2, D-4
B. A-4, B-1, C-3, D-2 (Correct Answer)
C. A-3, B-2, C-4, D-1
D. A-2, B-4, C-1, D-3

Explanation: ***A-4, B-1, C-3, D-2*** - **Morphine** is contraindicated in **head injury** as it can increase intracranial pressure and mask neurological symptoms. - **Amiodarone** is contraindicated in patients with **QT prolongation** due to its risk of inducing more severe arrhythmias like Torsades de Pointes. - **Vigabatrin** is contraindicated during **pregnancy** due to its potential for teratogenicity and adverse effects on fetal development. - **Estrogen preparations** are contraindicated in patients with a history of **thromboembolism** due to their increased risk of blood clot formation. *A-1, B-3, C-2, D-4* - This option incorrectly matches **Morphine** with QT prolongation and **Estrogen preparations** with head injury, which are not their primary contraindications. - It also incorrectly links **Vigabatrin** with thromboembolism and **Amiodarone** with pregnancy. *A-3, B-2, C-4, D-1* - This choice incorrectly associates **Morphine** with pregnancy and **Vigabatrin** with head injury, which are not the most critical or direct contraindications. - It also misaligns **Amiodarone** with thromboembolism and **Estrogen preparations** with QT prolongation. *A-2, B-4, C-1, D-3* - This option incorrectly matches **Morphine** with thromboembolism and **Amiodarone** with head injury, which are not their most significant contraindications. - It also incorrectly links **Vigabatrin** with QT prolongation and **Estrogen preparations** with pregnancy.

Question 9: Clozapine is used in:

A. Depression
B. Resistant schizophrenia (Correct Answer)
C. Mania
D. Delirium

Explanation: **Explanation:** **Clozapine** is an atypical (second-generation) antipsychotic and is considered the **gold standard** for the management of **Treatment-Resistant Schizophrenia (TRS)**. 1. **Why Option B is Correct:** Resistance in schizophrenia is defined as a lack of satisfactory clinical improvement despite the use of adequate doses of at least two different antipsychotics (including one atypical) for a duration of 6–8 weeks each. Clozapine is uniquely effective in these cases due to its complex receptor profile (low D2 affinity, high 5-HT2A, D4, and alpha-adrenergic blockade). It is the only antipsychotic proven to reduce suicidal behavior in schizophrenic patients. 2. **Why Other Options are Incorrect:** * **A. Depression:** First-line treatments are SSRIs/SNRIs. While some atypicals (like Quetiapine or Aripiprazole) are used as adjuncts in resistant depression, Clozapine is not used due to its side-effect profile. * **C. Mania:** Acute mania is treated with Lithium, Valproate, or standard antipsychotics (e.g., Olanzapine, Risperidone). Clozapine is reserved only for ultra-resistant cases, not as a standard indication. * **D. Delirium:** Low-dose Haloperidol is the drug of choice. Clozapine is contraindicated in delirium because its strong anticholinergic properties can worsen the confusional state. **High-Yield Clinical Pearls for NEET-PG:** * **Agranulocytosis:** The most dreaded side effect (occurs in ~1%). Mandatory **WBC monitoring** is required (weekly for the first 6 months). * **Seizures:** Clozapine carries a dose-dependent risk of seizures. * **Sialorrhea:** Paradoxical hypersalivation is a common, bothersome side effect. * **Myocarditis:** A rare but fatal side effect; monitor for tachycardia and chest pain. * **Metabolic Syndrome:** High risk of weight gain and diabetes (similar to Olanzapine).

Question 10: Which antipsychotic has anti-suicidal properties?

A. clozapine (Correct Answer)
B. chlorpromazine
C. aripiprazole
D. amisulpride

Explanation: **Explanation:** **Clozapine** is the correct answer because it is the only antipsychotic with a specifically FDA-approved indication for reducing the risk of recurrent suicidal behavior in patients with schizophrenia or schizoaffective disorder. This anti-suicidal effect is independent of its primary antipsychotic action and is believed to be mediated by its unique modulation of serotonergic (5-HT2A) and noradrenergic systems, which helps reduce impulsivity and aggression. **Analysis of Incorrect Options:** * **B. Chlorpromazine:** A typical (first-generation) antipsychotic primarily used for acute psychosis. While it treats positive symptoms, it has no proven specific anti-suicidal properties and may even worsen depressive symptoms in some patients. * **C. Aripiprazole:** A partial dopamine agonist. While effective for mood stabilization and augmentation in depression, it does not carry a specific indication for suicide prevention. * **D. Amisulpride:** A substituted benzamide that is effective for both positive and negative symptoms of schizophrenia, but lacks evidence for a direct anti-suicidal effect. **High-Yield Clinical Pearls for NEET-PG:** * **The "Rule of Two":** There are two main drugs in psychiatry known for reducing suicide risk: **Clozapine** (in Schizophrenia) and **Lithium** (in Bipolar Disorder). * **Clozapine Monitoring:** Due to the risk of **agranulocytosis**, regular monitoring of Absolute Neutrophil Count (ANC) is mandatory. * **Other Side Effects:** Clozapine is associated with the highest risk of seizures (dose-dependent), sialorrhea (drooling), myocarditis, and metabolic syndrome among antipsychotics. * **Indication:** It remains the gold standard for **Treatment-Resistant Schizophrenia** (defined as failure of two adequate trials of other antipsychotics).

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free